• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以异常气道血管生成作为哮喘治疗策略的靶点。

Targeting abnormal airway vascularity as a therapeutical strategy in asthma.

机构信息

Department of Internal Medicine, Chungnam National University School of Medicine, Jeonju, South Korea.

出版信息

Respirology. 2010 Apr;15(3):459-71. doi: 10.1111/j.1440-1843.2010.01724.x. Epub 2010 Mar 19.

DOI:10.1111/j.1440-1843.2010.01724.x
PMID:20337993
Abstract

Asthma is a chronic inflammatory disease of airways, characterized by airway hyperresponsiveness and airflow limitation with acute bronchoconstriction, swelling of the airway wall, chronic mucus plug formation and airway wall remodelling. Functional and structural changes in the vasculature of asthmatic airways have been documented, and the signalling mechanisms are complex and have recently attracted much attention. The vascular changes may affect inflammatory cell recruitment, airway hyperresponsiveness and the regulation of airway calibre, and further, the level of disease control. Many critical factors are involved in the pathophysiological regulation of vascular changes in bronchial asthma, and the actions of these factors must be very carefully orchestrated. By better understanding the complicated actions of each factor, we may be able to advance further in asthma treatment.

摘要

哮喘是一种气道的慢性炎症性疾病,其特征是气道高反应性和气流受限伴急性支气管痉挛、气道壁肿胀、慢性黏液栓形成和气道壁重塑。已经记录了哮喘气道中血管的功能和结构变化,其信号机制复杂,最近引起了广泛关注。血管变化可能影响炎症细胞募集、气道高反应性和气道口径的调节,进一步影响疾病的控制水平。许多关键因素参与了支气管哮喘中血管变化的病理生理调节,这些因素的作用必须非常精细地协调。通过更好地理解每个因素的复杂作用,我们可能能够在哮喘治疗方面取得进一步进展。

相似文献

1
Targeting abnormal airway vascularity as a therapeutical strategy in asthma.以异常气道血管生成作为哮喘治疗策略的靶点。
Respirology. 2010 Apr;15(3):459-71. doi: 10.1111/j.1440-1843.2010.01724.x. Epub 2010 Mar 19.
2
Therapeutic approach to vascular remodelling in asthma.
Pulm Pharmacol Ther. 2007;20(1):1-8. doi: 10.1016/j.pupt.2005.10.009. Epub 2005 Dec 9.
3
Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.布地奈德/福莫特罗可降低哮喘气道重塑过程中血管内皮生长因子(VEGF)及其受体1的表达。
Adv Ther. 2008 Apr;25(4):342-54. doi: 10.1007/s12325-008-0048-4.
4
Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma.吸入氟替卡松对哮喘中血管生成和血管内皮生长因子的影响。
Thorax. 2007 Apr;62(4):314-9. doi: 10.1136/thx.2006.069229. Epub 2006 Nov 14.
5
Inhaled steroids and airway remodelling in asthma.吸入性糖皮质激素与哮喘气道重塑
Acta Biomed. 2003 Dec;74(3):121-5.
6
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma.吸入性糖皮质激素:对支气管哮喘气道血管系统的影响
Eur Respir J. 2006 Jan;27(1):172-87. doi: 10.1183/09031936.06.00048605.
7
Angiogenesis in asthma.哮喘中的血管生成。
Clin Exp Allergy. 2009 Dec;39(12):1815-21. doi: 10.1111/j.1365-2222.2009.03385.x.
8
Asthma therapy and airway remodeling.哮喘治疗与气道重塑
J Allergy Clin Immunol. 2007 Nov;120(5):997-1009; quiz 1010-1. doi: 10.1016/j.jaci.2007.06.031. Epub 2007 Aug 6.
9
[The relation between morphologic and functional airway changes in bronchial asthma].[支气管哮喘中气道形态学与功能改变之间的关系]
Verh K Acad Geneeskd Belg. 2003;65(4):247-65; discussion 265-9.
10
Effects of pharmacological and non-pharmacological interventions.药物和非药物干预的效果。
Clin Respir J. 2010 May;4 Suppl 1:41-8. doi: 10.1111/j.1752-699X.2010.00196.x.

引用本文的文献

1
Anti-allergic and anti-inflammatory effects of Gastrodia elata Blume extract in ovalbumin-induced asthma rat model.天麻提取物对卵清蛋白诱导的哮喘大鼠模型的抗过敏和抗炎作用。
Lab Anim Res. 2025 Sep 16;41(1):21. doi: 10.1186/s42826-025-00252-8.
2
Does the airway circulation influence airflow obstruction in asthma?气道循环会影响哮喘中的气流阻塞吗?
BMJ Open Respir Res. 2025 Apr 17;12(1):e002575. doi: 10.1136/bmjresp-2024-002575.
3
Anti-angiogenic Properties of Bevacizumab Improve Respiratory System Inflammation in Ovalbumin-Induced Rat Model of Asthma.
贝伐单抗的抗血管生成特性改善卵清蛋白诱导的大鼠哮喘模型中的呼吸系统炎症。
Inflammation. 2021 Dec;44(6):2463-2475. doi: 10.1007/s10753-021-01516-w. Epub 2021 Aug 21.
4
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls.与健康对照相比,哮喘、慢性阻塞性肺疾病或系统性硬化症患者的呼出气分数温度。
Eur Clin Respir J. 2020 Apr 12;7(1):1747014. doi: 10.1080/20018525.2020.1747014. eCollection 2020.
5
Investigating the effectiveness of the L. (fenugreek) seeds in mild asthma: a randomized controlled trial.研究胡芦巴籽对轻度哮喘的疗效:一项随机对照试验。
Allergy Asthma Clin Immunol. 2018 May 2;14:19. doi: 10.1186/s13223-018-0238-9. eCollection 2018.
6
Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity.诱导型一氧化氮合酶作为变应原诱导的气道高反应性治疗靶点的潜力:与一氧化氮水平和聚(ADP-核糖)聚合酶活性的关键联系
Mediators Inflamm. 2016;2016:1984703. doi: 10.1155/2016/1984703. Epub 2016 Jul 20.
7
Markers of vascular perturbation correlate with airway structural change in asthma.血管功能紊乱标志物与哮喘的气道结构改变相关。
Am J Respir Crit Care Med. 2013 Jul 15;188(2):167-78. doi: 10.1164/rccm.201301-0185OC.
8
Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms.儿童哮喘治疗结局与血管内皮生长因子 A(VEGFA)多态性有关。
Mol Diagn Ther. 2012 Jun 1;16(3):173-80. doi: 10.1007/BF03262206.
9
PI3K-γ inhibition ameliorates acute lung injury through regulation of IκBα/NF-κB pathway and innate immune responses.PI3K-γ 抑制通过调节 IκBα/NF-κB 通路和固有免疫反应改善急性肺损伤。
J Clin Immunol. 2012 Apr;32(2):340-51. doi: 10.1007/s10875-011-9628-1. Epub 2011 Dec 24.
10
The roles of phytochemicals in bronchial asthma.植物化学物质在支气管哮喘中的作用。
Molecules. 2010 Oct 4;15(10):6810-34. doi: 10.3390/molecules15106810.